Medicine and Dentistry
Antibody
70%
Assessment
17%
Diagnosis
64%
Diagnostic Pathology
23%
Epitope
17%
Examination
23%
False Negative Result
17%
Hodgkin's Lymphoma
35%
Immunohistochemistry
70%
Immunotherapy
23%
Kidney Tissue
17%
Laboratory
35%
Lymphoma
17%
Monoclonal Antibody
70%
Neoplasm
46%
Non Small Cell Lung Cancer
70%
Oncology
23%
Pathology
23%
Patient
46%
Pembrolizumab
23%
Programmed Death-Ligand 1
70%
Specimen
17%
Therapeutic Procedure
70%
Tissues
17%
Tumor Cell
52%
Nursing and Health Professions
Clinical Outcome
9%
Cytokeratin 8
70%
Food and Drug Administration
9%
Immunohistochemistry
29%
Laboratory
60%
Molecular Weight
70%
Patient
29%
Quality Adjusted Life Year
9%
Quality Control
100%
Earth and Planetary Sciences
Accuracy
9%
Cost
40%
Country
9%
Economic Data
9%
Economics
29%
Estimate
20%
Growth
70%
Health Care
20%
Low Cost
9%
Model
20%
Quality Control
29%
Socioeconomic Impact
70%
Survival
20%
United States
20%